Cargando…
Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy
OBJECTIVE: To investigate whether the prices of new anticancer drugs correlated with their relative benefit despite negotiation. DESIGN: Retrospective cross-sectional study correlating new anticancer drugs prices with clinical outcomes. SETTING: We did a retrospective cross-sectional study including...
Autores principales: | Trotta, Francesco, Mayer, Flavia, Barone-Adesi, Francesco, Esposito, Immacolata, Punreddy, Ranadhir, Da Cas, Roberto, Traversa, Giuseppe, Perrone, Francesco, Martini, Nello, Gyawali, Bishal, Addis, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924817/ https://www.ncbi.nlm.nih.gov/pubmed/31826897 http://dx.doi.org/10.1136/bmjopen-2019-033728 |
Ejemplares similares
-
The timelines for the price and reimbursement authorization in Italy 2018–2020
por: Gallo, Valentina, et al.
Publicado: (2022) -
Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022) -
Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region
por: Trotta, Francesco, et al.
Publicado: (2017) -
Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?
por: Jommi, Claudio, et al.
Publicado: (2021) -
Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014–2019
por: Villa, Federico, et al.
Publicado: (2022)